October 15th marked SUDEP Action Day - one of the most important days in our annual calendar to raise awareness of Sudden Unexpected Death in Epilepsy and what can be done to mitigate the risks of SUDEP.
The EpiKNOW project was supported by Epilepsy Ireland and led by our colleagues in the Royal College of Surgeons.
Read our statement for SUDEP Action Day 2025.
See how you can support our campaign with your local representative.
We are delighted to have received 13 research proposals as part of our latest Research Funding Call.
FutureNeuro are seeking people living with post traumatic epilepsy, or their families/carers to join their panel to help guide their continuing research
A strategic awareness campaign has commenced since the 11th August with the aim of achieving a high level of participation in the recently established Sodium Valproate Inquiry.
As part of the continuing efforts to reduce the risks associated with the anti-seizure medication (ASM), Topirimate (Topamax), the Health Products Regulatory Authority (HPRA) have recently reissued patient information materials and reminders to prescribers and pharmacists about their obligations under the Pregnancy Prevention Programme (PPP) and risk reduction measures associated with the medication.
A study in Trinity College Dublin is looking to explore how we sense internal body signals and emotional regulation.
Epilepsy Ireland’s Annual General Meeting (AGM) takes place this evening (Monday 8th Sept) at 6pm via Zoom.
Due to a technical issue, the original link circulated to all members three weeks ago has expired and no longer works. Members have been issued with a new link for the meeting this morning by email.
If you are a member of Epilepsy Ireland and you were planning to attend the AGM, please check your email for the updated link.